{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T21:20:06Z","timestamp":1757625606472,"version":"3.44.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T00:00:00Z","timestamp":1756166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Emerging & Pandemic Infections Consortium, University of Toronto, Canada","award":["Doctoral Award"],"award-info":[{"award-number":["Doctoral Award"]}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["Discovery Grant"],"award-info":[{"award-number":["Discovery Grant"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Vaccine-driven evolution can erode the beneficial effects of vaccination and is a concern, especially for newly introduced vaccines. While obvious candidates for vaccine-driven evolution are the precise parasite antigens that are the targets of vaccine-induced immunity, traits underlying parasite virulence may also evolve. Previous experimental work in rodent malaria demonstrated that evolution in vaccinated hosts resulted in increased parasite virulence, as measured by anemia (minimum red blood cell density). However, no genetic changes were detected at vaccine target sites, leaving the underlying traits or their interactions with host responses unclear. Using a hierarchical Bayesian framework, we fitted a mathematical model of within-host malaria infection dynamics to experimental time series data from infections in mice inoculated with parasites that had evolved in either vaccinated mice or sham-vaccinated (control) mice. We compared parameter estimates across treatments to understand which parasite traits could plausibly explain differences in infection dynamics and virulence.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Vaccine-evolved parasites elicited lower targeted immune killing and anemia-driven erythropoiesis, differences that were observed at the level of treatment means and when accounting for individual-level variation. We validated our model by calculating early-infection parasite multiplication rates, finding no differences across treatments (either experimental or simulated)\u2014differences that would be expected if the vaccine target antigen (AMA-1) had evolved.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our results emphasize the complexity of virulence, showing that parasite modulation of host responses can influence disease severity. We also highlight the important role for evolution of parasite traits beyond target antigens in response to vaccination.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12915-025-02366-w","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T13:33:19Z","timestamp":1756215199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Understanding the traits underlying vaccine-driven virulence evolution in malaria parasites"],"prefix":"10.1186","volume":"23","author":[{"given":"Youngseo","family":"Jeong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsukushi","family":"Kamiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Mideo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,26]]},"reference":[{"key":"2366_CR1","doi-asserted-by":"publisher","first-page":"e1002198","DOI":"10.1371\/journal.pbio.1002198","volume":"13","author":"AF Read","year":"2015","unstructured":"Read AF, Baigent SJ, Powers C, Kgosana LB, Blackwell L, Smith LP, et al. Imperfect vaccination can enhance the transmission of highly virulent pathogens. Fraser C, editor. PLoS Biol. 2015;13:e1002198.","journal-title":"PLoS Biol"},{"key":"2366_CR2","doi-asserted-by":"publisher","first-page":"12878","DOI":"10.1073\/pnas.1717159115","volume":"115","author":"DA Kennedy","year":"2018","unstructured":"Kennedy DA, Read AF. Why the evolution of vaccine resistance is less of a concern than the evolution of drug resistance. Proc Natl Acad Sci USA. 2018;115:12878\u201386.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2366_CR3","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.meegid.2009.10.007","volume":"10","author":"FR Mooi","year":"2010","unstructured":"Mooi FR. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infect Genet Evol. 2010;10:36\u201349.","journal-title":"Infect Genet Evol"},{"key":"2366_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0030168","volume":"3","author":"AB Brueggemann","year":"2007","unstructured":"Brueggemann AB, Pai R, Crook DW, Beall B. Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS Pathog. 2007;3: e168.","journal-title":"PLoS Pathog"},{"key":"2366_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3001804","volume":"20","author":"T Day","year":"2022","unstructured":"Day T, Kennedy DA, Read AF, Gandon S. Pathogen evolution during vaccination campaigns. PLoS Biol. 2022;20: e3001804.","journal-title":"PLoS Biol"},{"key":"2366_CR6","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1111\/j.1558-5646.2012.01803.x","volume":"67","author":"KE Atkins","year":"2013","unstructured":"Atkins KE, Read AF, Savill NJ, Renz KG, Islam AF, Walkden-Brown SW, et al. Vaccination and reduced cohort duration can drive virulence evolution: Marek\u2019s disease virus and industrialized agriculture: Marek\u2019s disease virus virulence evolution drivers. Evolution. 2013;67:851\u201360.","journal-title":"Evolution"},{"key":"2366_CR7","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/414751a","volume":"414","author":"S Gandon","year":"2001","unstructured":"Gandon S, Mackinnon MJ, Nee S, Read AF. Imperfect vaccines and the evolution of pathogen virulence. Nature. 2001;414:6.","journal-title":"Nature"},{"key":"2366_CR8","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1093\/emph\/eoac015","volume":"10","author":"JJ Bull","year":"2022","unstructured":"Bull JJ, Antia R. Which \u2018imperfect vaccines\u2019 encourage the evolution of higher virulence? Evol Med Public Health. 2022;10:202\u201313.","journal-title":"Evol Med Public Health"},{"key":"2366_CR9","doi-asserted-by":"publisher","first-page":"20190642","DOI":"10.1098\/rsif.2019.0642","volume":"16","author":"IF Miller","year":"2019","unstructured":"Miller IF, Metcalf CJ. Vaccine-driven virulence evolution: consequences of unbalanced reductions in mortality and transmission and implications for pertussis vaccines. J R Soc Interface. 2019;16:20190642.","journal-title":"J R Soc Interface"},{"key":"2366_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001368","volume":"10","author":"VC Barclay","year":"2012","unstructured":"Barclay VC, Sim D, Chan BHK, Nell LA, Rabaa MA, Bell AS, et al. The evolutionary consequences of blood-stage vaccination on the rodent malaria Plasmodium chabaudi. PLoS Biol. 2012;10: e1001368.","journal-title":"PLoS Biol"},{"key":"2366_CR11","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.pt.2007.12.002","volume":"24","author":"EJ Remarque","year":"2008","unstructured":"Remarque EJ, Faber BW, Kocken CHM, Thomas AW. Apical membrane antigen 1: a malaria vaccine candidate in review. Trends Parasitol. 2008;24:74\u201384.","journal-title":"Trends Parasitol"},{"key":"2366_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-016-1466-4","volume":"15","author":"MA Thera","year":"2016","unstructured":"Thera MA, Coulibaly D, Kone AK, Guindo AB, Traore K, Sall AH, et al. Phase 1 randomized controlled trial to evaluate the safety and immunogenicity of recombinant Pichia pastoris-expressed Plasmodium falciparum apical membrane antigen 1 (PfAMA1-FVO [25-545]) in healthy Malian adults in Bandiagara. Malar J. 2016;15: 442.","journal-title":"Malar J"},{"key":"2366_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232112762","volume":"23","author":"A Dumarchey","year":"2022","unstructured":"Dumarchey A, Lavazec C, Verdier F. Erythropoiesis and malaria, a multifaceted interplay. Int J Mol Sci. 2022;23: 12762.","journal-title":"Int J Mol Sci"},{"key":"2366_CR14","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1039\/C7MB00502D","volume":"13","author":"XY Yam","year":"2017","unstructured":"Yam XY, Preiser PR. Host immune evasion strategies of malaria blood stage parasite. Mol Biosyst. 2017;13:2498\u2013508.","journal-title":"Mol Biosyst"},{"key":"2366_CR15","doi-asserted-by":"publisher","first-page":"4563","DOI":"10.1073\/pnas.96.8.4563","volume":"96","author":"RE Hayward","year":"1999","unstructured":"Hayward RE, Tiwari B, Piper KP, Baruch DI, Day KP. Virulence and transmission success of the malarial parasite Plasmodium falciparum. Proc Natl Acad Sci U S A. 1999;96:4563\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2366_CR16","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2022.2150456","volume":"14","author":"IS Walker","year":"2023","unstructured":"Walker IS, Rogerson SJ. Pathogenicity and virulence of malaria: sticky problems and tricky solutions. Virulence. 2023;14: 2150456.","journal-title":"Virulence"},{"key":"2366_CR17","doi-asserted-by":"publisher","first-page":"e1000322","DOI":"10.1371\/journal.ppat.1000322","volume":"5","author":"M Treeck","year":"2009","unstructured":"Treeck M, Zacherl S, Herrmann S, Cabrera A, Kono M, Struck NS, et al. Functional analysis of the leading malaria vaccine candidate AMA-1 reveals an essential role for the cytoplasmic domain in the invasion process. Blackman M, editor. PLoS Pathog. 2009;5:e1000322.","journal-title":"PLoS Pathog"},{"key":"2366_CR18","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.65846","volume":"10","author":"T Kamiya","year":"2021","unstructured":"Kamiya T, Davis NM, Greischar MA, Schneider D, Mideo N. Linking functional and molecular mechanisms of host resilience to malaria infection. Elife. 2021;10: e65846.","journal-title":"Elife"},{"key":"2366_CR19","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nri1311","volume":"4","author":"MM Stevenson","year":"2004","unstructured":"Stevenson MM, Riley EM. Innate immunity to malaria. Nat Rev Immunol. 2004;4:169\u201380.","journal-title":"Nat Rev Immunol"},{"key":"2366_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1037\/met0000275","volume":"26","author":"DJ Schad","year":"2021","unstructured":"Schad DJ, Betancourt M, Vasishth S. Toward a principled Bayesian workflow in cognitive science. Psychol Methods. 2021;26:103\u201326.","journal-title":"Psychol Methods"},{"key":"2366_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1600-0587.2012.07348.x","volume":"36","author":"CF Dormann","year":"2013","unstructured":"Dormann CF, Elith J, Bacher S, Buchmann C, Carl G, Carr\u00e9 G, et al. Collinearity: a review of methods to deal with it and a simulation study evaluating their performance. Ecography. 2013;36:27\u201346.","journal-title":"Ecography"},{"key":"2366_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50770-7","volume":"15","author":"D Angage","year":"2024","unstructured":"Angage D, Chmielewski J, Maddumage JC, Hesping E, Caiazzo S, Lai KH, et al. A broadly cross-reactive i-body to AMA1 potently inhibits blood and liver stages of Plasmodium parasites. Nat Commun. 2024;15: 7206.","journal-title":"Nat Commun"},{"key":"2366_CR23","doi-asserted-by":"publisher","first-page":"13275","DOI":"10.1073\/pnas.1110303108","volume":"108","author":"P Srinivasan","year":"2011","unstructured":"Srinivasan P, Beatty WL, Diouf A, Herrera R, Ambroggio X, Moch JK, et al. Binding of Plasmodium merozoite proteins RON2 and AMA1 triggers commitment to invasion. Proc Natl Acad Sci U S A. 2011;108:13275\u201380.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2366_CR24","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/infdis\/jit417","volume":"209","author":"N Thawani","year":"2014","unstructured":"Thawani N, Tam M, Bellemare M-J, Bohle DS, Olivier M, De Souza JB, et al. Plasmodium products contribute to severe malarial anemia by inhibiting erythropoietin-induced proliferation of erythroid precursors. J Infect Dis. 2014;209:140\u20139.","journal-title":"J Infect Dis"},{"key":"2366_CR25","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1017\/S0031182018000653","volume":"145","author":"D Boehm","year":"2018","unstructured":"Boehm D, Healy L, Ring S, Bell A. Inhibition of ex vivo erythropoiesis by secreted and haemozoin-associated Plasmodium falciparum products. Parasitology. 2018;145:1865\u201375.","journal-title":"Parasitology"},{"key":"2366_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0010444","volume":"5","author":"BF Kochin","year":"2010","unstructured":"Kochin BF, Yates AJ, de Roode JC, Antia R. On the control of acute rodent malaria infections by innate immunity. PLoS One. 2010;5: e10444.","journal-title":"PLoS One"},{"key":"2366_CR27","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1128\/iai.64.8.3310-3317.1996","volume":"64","author":"PE Crewther","year":"1996","unstructured":"Crewther PE, Matthew ML, Flegg RH, Anders RF. Protective immune responses to apical membrane antigen 1 of Plasmodium chabaudi involve recognition of strain-specific epitopes. Infect Immun. 1996;64:3310\u20137.","journal-title":"Infect Immun"},{"key":"2366_CR28","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1046\/j.1365-3024.1999.00254.x","volume":"21","author":"T Scorza","year":"1999","unstructured":"Scorza T, Magez S, Brys L, De Baetselier P. Hemozoin is a key factor in the induction of malaria-associated immunosuppression. Parasite Immunol. 1999;21:545\u201354.","journal-title":"Parasite Immunol"},{"key":"2366_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/jbiol34","volume":"5","author":"OR Millington","year":"2006","unstructured":"Millington OR, Di Lorenzo C, Phillips RS, Garside P, Brewer JM. Suppression of adaptive immunity to heterologous antigens during Plasmodium infection through hemozoin-induced failure of dendritic cell function. J Biol. 2006;5:5.","journal-title":"J Biol"},{"key":"2366_CR30","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1128\/IAI.74.5.2628-2636.2006","volume":"74","author":"AM Coley","year":"2006","unstructured":"Coley AM, Parisi K, Masciantonio R, Hoeck J, Casey JL, Murphy VJ, et al. The most polymorphic residue on Plasmodium falciparum apical membrane antigen 1 determines binding of an invasion-inhibitory antibody. Infect Immun. 2006;74:2628\u201336.","journal-title":"Infect Immun"},{"key":"2366_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1009801","volume":"18","author":"MT Naung","year":"2022","unstructured":"Naung MT, Martin E, Munro J, Mehra S, Guy AJ, Laman M, et al. Global diversity and balancing selection of 23 leading Plasmodium falciparum candidate vaccine antigens. PLoS Comput Biol. 2022;18: e1009801.","journal-title":"PLoS Comput Biol"},{"key":"2366_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00743","volume":"8","author":"H Spiegel","year":"2017","unstructured":"Spiegel H, Boes A, Fendel R, Reimann A, Schillberg S, Fischer R. Immunization with the malaria diversity-covering blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 DiCo in complex with its natural ligand PfRon2 does not improve the in vitro efficacy. Front Immunol. 2017;8: 743.","journal-title":"Front Immunol"},{"key":"2366_CR33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1008115","author":"MA Thera","year":"2011","unstructured":"Thera MA, Coulibaly D, Ouattara A, Traore K, Diallo DA, Dolo A, et al. A field trial to assess a blood-stage malaria vaccine. N Engl J Med. 2011. https:\/\/doi.org\/10.1056\/NEJMoa1008115.","journal-title":"N Engl J Med"},{"key":"2366_CR34","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1038\/s41467-018-04219-3","volume":"9","author":"Q He","year":"2018","unstructured":"He Q, Pilosof S, Tiedje KE, Ruybal-Pes\u00e1ntez S, Artzy-Randrup Y, Baskerville EB, et al. Networks of genetic similarity reveal non-neutral processes shape strain structure in Plasmodium falciparum. Nat Commun. 2018;9:1817.","journal-title":"Nat Commun"},{"key":"2366_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1008577","volume":"17","author":"AOB Whitlock","year":"2021","unstructured":"Whitlock AOB, Juliano JJ, Mideo N. Immune selection suppresses the emergence of drug resistance in malaria parasites but facilitates its spread. PLoS Comput Biol. 2021;17: e1008577.","journal-title":"PLoS Comput Biol"},{"key":"2366_CR36","doi-asserted-by":"publisher","first-page":"e1010643","DOI":"10.1371\/journal.ppat.1010643","volume":"18","author":"P Fernandes","year":"2022","unstructured":"Fernandes P, Loubens M, Le Borgne R, Marinach C, Ardin B, Briquet S, et al. The AMA1-RON complex drives Plasmodium sporozoite invasion in the mosquito and mammalian hosts. Blackman MJ, editor. PLoS Pathog. 2022;18:e1010643.","journal-title":"PLoS Pathog"},{"key":"2366_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1008211","volume":"16","author":"T Kamiya","year":"2020","unstructured":"Kamiya T, Greischar MA, Schneider DS, Mideo N. Uncovering drivers of dose-dependence and individual variation in malaria infection outcomes. PLoS Comput Biol. 2020;16: e1008211.","journal-title":"PLoS Comput Biol"},{"key":"2366_CR38","doi-asserted-by":"publisher","first-page":"22386","DOI":"10.1073\/pnas.1908147116","volume":"116","author":"N Wale","year":"2019","unstructured":"Wale N, Jones MJ, Sim DG, Read AF, King AA. The contribution of host cell-directed vs. parasite-directed immunity to the disease and dynamics of malaria infections. Proc Natl Acad Sci USA. 2019;116:22386\u201392.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2366_CR39","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1182\/blood-2010-04-202911","volume":"117","author":"PA Buffet","year":"2011","unstructured":"Buffet PA, Safeukui I, Deplaine G, Brousse V, Prendki V, Thellier M, et al. The pathogenesis of Plasmodium falciparum malaria in humans: insights from splenic physiology. Blood. 2011;117:381\u201392.","journal-title":"Blood"},{"key":"2366_CR40","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.actatropica.2009.08.017","volume":"112","author":"NW Awah","year":"2009","unstructured":"Awah NW, Troye-Blomberg M, Berzins K, Gysin J. Mechanisms of malarial anaemia: potential involvement of the Plasmodium falciparum low molecular weight rhoptry-associated proteins. Acta Trop. 2009;112:295\u2013302.","journal-title":"Acta Trop"},{"key":"2366_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1000416","volume":"5","author":"NJ Savill","year":"2009","unstructured":"Savill NJ, Chadwick W, Reece SE. Quantitative analysis of mechanisms that govern red blood cell age structure and dynamics during anaemia. PLoS Comput Biol. 2009;5: e1000416.","journal-title":"PLoS Comput Biol"},{"key":"2366_CR42","doi-asserted-by":"publisher","first-page":"855795","DOI":"10.3389\/fimmu.2022.855795","volume":"13","author":"AM Scovino","year":"2022","unstructured":"Scovino AM, Totino PRR, Morrot A. Eryptosis as a new insight in malaria pathogenesis. Front Immunol. 2022;13:855795.","journal-title":"Front Immunol"},{"key":"2366_CR43","doi-asserted-by":"publisher","DOI":"10.1086\/591684","volume":"172","author":"N Mideo","year":"2008","unstructured":"Mideo N, Barclay VC, Chan BHK, Savill NJ, Read AF, Day T. Understanding and predicting strain-specific patterns of pathogenesis in the rodent malaria Plasmodium chabaudi. Am Nat. 2008;172: E214\u201338.","journal-title":"Am Nat"},{"key":"2366_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1000946","volume":"6","author":"MR Miller","year":"2010","unstructured":"Miller MR, R\u00e5berg L, Read AF, Savill NJ. Quantitative analysis of immune response and erythropoiesis during rodent malarial infection. PLoS Comput Biol. 2010;6: e1000946.","journal-title":"PLoS Comput Biol"},{"issue":"3","key":"2366_CR45","doi-asserted-by":"publisher","first-page":"455","DOI":"10.2307\/3280000","volume":"63","author":"RO McAlister","year":"1977","unstructured":"McAlister RO. Time-dependent loss of invasive ability of Plasmodium berghei merozoites in vitro. J Parasitol. 1977;63:455.","journal-title":"J Parasitol"}],"container-title":["BMC Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12915-025-02366-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12915-025-02366-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12915-025-02366-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T18:52:21Z","timestamp":1757443941000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbiol.biomedcentral.com\/articles\/10.1186\/s12915-025-02366-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,26]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2366"],"URL":"https:\/\/doi.org\/10.1186\/s12915-025-02366-w","relation":{},"ISSN":["1741-7007"],"issn-type":[{"type":"electronic","value":"1741-7007"}],"subject":[],"published":{"date-parts":[[2025,8,26]]},"assertion":[{"value":"25 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The data analyzed in this article was previously published [] in accordance with the recommendations and approvals described in the original paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"267"}}